Home Applications 215003 Application 215003
Type ANDA
Sponsor NOVITIUM PHARMA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 PAROXETINE HYDROCHLORIDE PAROXETINE HYDROCHLORIDE SUSPENSION;ORAL EQ 10MG BASE/5ML No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215003-001 PAROXETINE HYDROCHLORIDE PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB RS 2021-09-03
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A215003-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL RS 2021-09-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL RS 2021-09-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL RS 2021-09-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL RS 2021-09-03 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL RS 2021-09-03 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL RS 2021-09-03 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL RS 2021-09-03 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 782e0a99824c…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB 2021-09-03 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215003-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE/5ML SUSPENSION / ORAL AB RS 2021-09-03 a50c72e98297…
Observed Orange Book normalized TE history# Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 70954-319 Paroxetine Paroxetine Novitium Pharma LLC ANDA Current 70954-319 Paroxetine Paroxetine Novitium Pharma LLC ANDA Current 70954-319 Paroxetine Paroxetine ANI Pharmaceuticals, Inc. ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 68924 ORIG 2021-10-08